During the past decade, Charles Nicolle Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Charles Nicolle Hospital" #1 sponsor was "OxThera" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "C.T. Development America, Inc." with 1 trials sponsored, "Heart Initiative" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Charles Nicolle Hospital" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Centre Hospitalier Régional Universitaire de Nancy" with 1 trials as a collaborator, "George Clinical Pty Ltd" with 1 trials as a collaborator, "Hôpitaux Universitaires Saint-Louis-Lariboisière" with 1 trials as a collaborator and "Inserm UMRS 942" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Charles Nicolle Hospital" are "Amyloidosis" (1 trials), "Cardiovascular Disease" (1 trials), "Chronic Kidney Diseases" (1 trials), "Dialysis-dependent Kidney Failure" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "Charles Nicolle Hospital" in a lesser frequency.

Most popular intervention types in "Charles Nicolle Hospital" are "Drug" (5 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Diosmectite (Smecta®)" (1 trials), "High Intensity Care" (1 trials), "Interferon beta-1a" (1 trials) and "Interferon beta-1a-matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Charles Nicolle Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Charles Nicolle Hospital". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Charles Nicolle Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Charles Nicolle Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".